Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.

Alkhatabi HA, McLornan DP, Kulasekararaj AG, Malik F, Seidl T, Darling D, Gaken J, Mufti GJ.

Oncotarget. 2016 Jul 26;7(30):47875-47890. doi: 10.18632/oncotarget.10293.

2.

Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.

Kamio T, Gu BW, Olson TS, Zhang Y, Mason PJ, Bessler M.

PLoS One. 2016 Apr 4;11(4):e0152263. doi: 10.1371/journal.pone.0152263. eCollection 2016.

3.

Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.

Gañán-Gómez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, Boyano-Adánez Mdel C, García-Manero G.

PLoS One. 2014 Apr 1;9(4):e93404. doi: 10.1371/journal.pone.0093404. eCollection 2014.

4.

Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.

Wen J, Huang Y, Li H, Zhang X, Cheng P, Deng D, Peng Z, Luo J, Zhao W, Lai Y, Liu Z.

Int J Hematol. 2017 Jun;105(6):777-783. doi: 10.1007/s12185-017-2201-9. Epub 2017 Feb 21.

PMID:
28224273
5.

Deletion 5q MDS: molecular and therapeutic implications.

Komrokji RS, Padron E, Ebert BL, List AF.

Best Pract Res Clin Haematol. 2013 Dec;26(4):365-75. doi: 10.1016/j.beha.2013.10.013. Epub 2013 Oct 16. Review.

PMID:
24507813
6.

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.

Kumar MS, Narla A, Nonami A, Mullally A, Dimitrova N, Ball B, McAuley JR, Poveromo L, Kutok JL, Galili N, Raza A, Attar E, Gilliland DG, Jacks T, Ebert BL.

Blood. 2011 Oct 27;118(17):4666-73. doi: 10.1182/blood-2010-12-324715. Epub 2011 Aug 26.

7.

Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.

Challagundla KB, Sun XX, Zhang X, DeVine T, Zhang Q, Sears RC, Dai MS.

Mol Cell Biol. 2011 Oct;31(19):4007-21. doi: 10.1128/MCB.05810-11. Epub 2011 Aug 1.

8.

The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.

Dong Z, Zhu C, Zhan Q, Jiang W.

Oncotarget. 2017 Feb 21;8(8):13240-13252. doi: 10.18632/oncotarget.14658.

9.

Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.

Hussein K, Theophile K, Büsche G, Schlegelberger B, Göhring G, Kreipe H, Bock O.

Leuk Res. 2010 Mar;34(3):328-34. doi: 10.1016/j.leukres.2009.06.014. Epub 2009 Jul 16.

PMID:
19615744
10.

miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes.

Kuang X, Wei C, Zhang T, Yang Z, Chi J, Wang L.

Int J Oncol. 2016 Nov;49(5):1921-1930. doi: 10.3892/ijo.2016.3689. Epub 2016 Sep 13.

PMID:
27633496
11.

Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.

Wang L, Luo J, Nian Q, Xiao Q, Yang Z, Liu L.

Hematology. 2014 Jun;19(4):225-31. doi: 10.1179/1607845413Y.0000000127. Epub 2013 Nov 25.

PMID:
24074450
12.

Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.

Li X, Xu F, Chang C, Byon J, Papayannopoulou T, Deeg HJ, Marcondes AM.

Haematologica. 2013 Mar;98(3):414-9. doi: 10.3324/haematol.2012.071753. Epub 2012 Sep 14.

13.

Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.

Zhou L, Opalinska J, Sohal D, Yu Y, Mo Y, Bhagat T, Abdel-Wahab O, Fazzari M, Figueroa M, Alencar C, Zhang J, Kambhampati S, Parmar S, Nischal S, Hueck C, Suzuki M, Freidman E, Pellagatti A, Boultwood J, Steidl U, Sauthararajah Y, Yajnik V, McMahon C, Gore SD, Platanias LC, Levine R, Melnick A, Wickrema A, Greally JM, Verma A.

J Biol Chem. 2011 Jul 15;286(28):25211-23. doi: 10.1074/jbc.M111.235028. Epub 2011 Apr 30.

14.

Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.

Vasilatou D, Papageorgiou SG, Kontsioti F, Kontos CK, Tsiotra P, Mpakou V, Pavlou MA, Economopoulou C, Dimitriadis G, Dervenoulas J, Pappa V.

Leuk Res. 2013 Mar;37(3):251-8. doi: 10.1016/j.leukres.2012.11.011. Epub 2012 Dec 14.

PMID:
23246221
15.

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Dostalova Merkerova M, Krejcik Z, Votavova H, Belickova M, Vasikova A, Cermak J.

Eur J Hum Genet. 2011 Mar;19(3):313-9. doi: 10.1038/ejhg.2010.209. Epub 2010 Dec 8.

16.

Genetic deletions in AML and MDS.

Ebert BL.

Best Pract Res Clin Haematol. 2010 Dec;23(4):457-61. doi: 10.1016/j.beha.2010.09.006. Epub 2010 Nov 4. Review.

17.

Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.

Wang HT, Chen TY, Weng CW, Yang CH, Tang MS.

Oncotarget. 2016 Dec 6;7(49):80450-80464. doi: 10.18632/oncotarget.12608.

18.

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.

Lee DW, Futami M, Carroll M, Feng Y, Wang Z, Fernandez M, Whichard Z, Chen Y, Kornblau S, Shpall EJ, Bueso-Ramos CE, Corey SJ.

Oncogene. 2012 Sep 13;31(37):4085-94. doi: 10.1038/onc.2011.579. Epub 2012 Jan 16.

PMID:
22249254
19.

p53 is positively regulated by miR-542-3p.

Wang Y, Huang JW, Castella M, Huntsman DG, Taniguchi T.

Cancer Res. 2014 Jun 15;74(12):3218-27. doi: 10.1158/0008-5472.CAN-13-1706. Epub 2014 Apr 24.

20.

MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression.

Jang SJ, Choi IS, Park G, Moon DS, Choi JS, Nam MH, Yoon SY, Choi CH, Kang SH.

Leuk Res. 2016 Aug;47:172-7. doi: 10.1016/j.leukres.2016.06.003. Epub 2016 Jun 16.

PMID:
27379838

Supplemental Content

Support Center